Joint controllership arrangement with regard to EudraVigilance Human (EV)
Submitted by Anonymous (not verified) on 23 January 2026 - 16:15
Joint controllership arrangement with regard to EudraVigilance Human (EV)
SMS guidance for external users
Submitted by Anonymous (not verified) on 23 January 2026 - 16:10
SMS guidance for external users
PRAC work plan 2026
Submitted by Anonymous (not verified) on 23 January 2026 - 15:56
PRAC work plan 2026
Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide,brimonidine tartrate, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 23 January 2026 - 15:50
Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide,brimonidine tartrate, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Nevanac, nepafenac, Date of authorisation: 11/12/2007, Revision: 21, Status: Authorised
Submitted by Anonymous (not verified) on 23 January 2026 - 15:40
Human medicines European public assessment report (EPAR): Nevanac, nepafenac, Date of authorisation: 11/12/2007, Revision: 21, Status: Authorised
Demonstration of efficacy of ectoparasiticides - Scientific guideline
Submitted by Anonymous (not verified) on 23 January 2026 - 15:00
Demonstration of efficacy of ectoparasiticides - Scientific guideline
PDCO work plan 2026
Submitted by Anonymous (not verified) on 23 January 2026 - 14:54
PDCO work plan 2026
Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Date of authorisation: 30/06/2015, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 23 January 2026 - 14:40
Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Date of authorisation: 30/06/2015, Revision: 19, Status: Authorised
Ilona Reischl re-elected as chair of Committee for Advanced Therapies
Submitted by Anonymous (not verified) on 23 January 2026 - 12:25
Ilona Reischl re-elected as chair of Committee for Advanced Therapies
Concept paper on the development of a guideline for using owner assessment as efficacy parameter
Submitted by Anonymous (not verified) on 23 January 2026 - 10:11
Concept paper on the development of a guideline for using owner assessment as efficacy parameter